Verastem Oncology
VSTM
#6930
Rank
NZ$1.29 B
Marketcap
NZ$14.26
Share price
3.90%
Change (1 day)
-3.27%
Change (1 year)

Market capitalization of Verastem Oncology (VSTM)

Market cap: NZ$1.29 Billion

As of October 2026 Verastem Oncology has a market cap of NZ$1.29 Billion. This makes Verastem Oncology the world's 6930th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Verastem Oncology from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$1.29 B23.2%
2025NZ$1.04 B258.02%
2024NZ$0.29 B-9.98%
2023NZ$0.32 B144.2%
2022NZ$0.13 B-75.64%
2021NZ$0.54 B9.1%
2020NZ$0.50 B214.4%
2019NZ$0.15 B-56.88%
2018NZ$0.36 B69.23%
2017NZ$0.21 B265.24%
2016NZ$59.81 M-40.42%
2015NZ$0.10 B-68.43%
2014NZ$0.31 B-9.5%
2013NZ$0.35 B61.48%
2012NZ$0.21 B

End of Day market cap according to different sources

On Oct 5th, 2026 the market cap of Verastem Oncology was reported to be:

NZ$1.29 Billion
by Nasdaq info icon info icon
NZ$1.29 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$278.46 B 21,463.35%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$44.61 B 3,354.97%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$166.23 B 12,772.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
NZ$3.41 M-99.74%๐Ÿ‡บ๐Ÿ‡ธ USA